Credit Suisse’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $368K | Buy |
20,166
+2,867
| +17% | +$52.3K | ﹤0.01% | 2755 |
|
|
2023
Q4 | $189K | Buy |
+17,299
| New | +$189K | ﹤0.01% | 2987 |
|
|
2023
Q1 | – | Sell |
-1
| Closed | -$9 | – | 3401 |
|
|
2022
Q4 | $9 | Sell |
1
-194
| -99% | -$1.75K | ﹤0.01% | 3733 |
|
|
2022
Q3 | $2K | Buy |
195
+159
| +442% | +$1.63K | ﹤0.01% | 3701 |
|
|
2022
Q2 | $0 | Buy |
+36
| New | – | ﹤0.01% | 4019 |
|
|
2021
Q4 | – | Sell |
-98,395
| Closed | -$1.63M | – | 3644 |
|
|
2021
Q3 | $1.63M | Sell |
98,395
-112,773
| -53% | -$1.87M | ﹤0.01% | 2277 |
|
|
2021
Q2 | $4.51M | Buy |
211,168
+127,116
| +151% | +$2.71M | ﹤0.01% | 1609 |
|
|
2021
Q1 | $2.73M | Buy |
+84,052
| New | +$2.73M | ﹤0.01% | 1947 |
|